首页|期刊导航|中国中药杂志|基于Nrf2/SLC7A11/GPX4信号通路探究固本咳喘颗粒对慢性阻塞性肺疾病大鼠模型的作用机制

基于Nrf2/SLC7A11/GPX4信号通路探究固本咳喘颗粒对慢性阻塞性肺疾病大鼠模型的作用机制OA

Action mechanism of Guben Kechuan Granules in rat models of chronic obstructive pulmonary disease based on Nrf2/SLC7A11/GPX4 signaling pathway

中文摘要英文摘要

基于核因子 E2 相关因子 2(Nrf2)/溶质载体家族 7 成员 11(SLC7A11)/谷胱甘肽过氧化物酶 4(GPX4)信号通路探讨固本咳喘颗粒治疗慢性阻塞性肺疾病(COPD)的作用机制.该研究采用脂多糖(LPS)联合猪胰蛋白酶(PPE)构建 COPD 大鼠模型,设固本咳喘颗粒低、高剂量(0.54、1.08 g·kg-1)组和地塞米松(0.2 mg·kg-1)组,干预 4 周后,检测大鼠体质量、肺功能;HE 染色观察肺组织病理改变;透射电镜(TEM)观察肺组织线粒体结构;生化法检测肺组织丙二醛(MDA)、还原型谷胱甘肽(GSH)、Fe2+、总铁离子水平;ELISA 试剂盒测定血清炎症因子水平;Western blot 法检测肺组织 Nrf2、SLC7A11、GPX4 蛋白表达情况;RT-qPCR 检测肺组织 Nrf2、SLC7A11、GPX4 mRNA 水平.结果表明,与模型组相比,固本咳喘颗粒组大鼠体质量增加、肺功能改善,肺组织病理损伤及炎症减轻,血清肿瘤坏死因子-α(TNF-α)、白细胞介素(IL)-1β、IL-6、IL-8、转化生长因子-β(TGF-β)明显下降,IL-10 水平明显升高;肺组织线粒体损伤明显减轻,双层膜结构清晰、内膜嵴形态恢复;肺组织 MDA、Fe2+、总铁离子水平降低、GSH 水平有所恢复,表明固本咳喘颗粒可有效减轻 COPD 大鼠氧化应激与铁死亡,改善肺功能,减轻炎症;分子机制研究显示,与模型组相比,固本咳喘颗粒组大鼠Nrf2、SLC7A11、GPX4 蛋白及mRNA 表达水平均明显升高.综上,固本咳喘颗粒能有效改善 COPD 大鼠肺功能,减轻炎症,其作用机制可能与激活 Nrf2/SLC7A11/GPX4 通路、抑制肺组织铁死亡有关.

This paper aims to investigate the action mechanism of Guben Kechuan Granules in the treatment of chronic obstructive pulmonary disease(COPD)based on the nuclear factor erythroid 2-related factor 2(Nrf2)/solute carrier family 7 member 11(SLC7A11)/glutathione peroxidase 4(GPX4)signaling pathway.In this study,a COPD rat model was constructed using lipopolysaccharide(LPS)combined with porcine pancreatic elastase(PPE).The rats were divided into a low-dose Guben Kechuan Granule group(0.54 g·kg-1),a high-dose Guben Kechuan Granule group(1.08 g·kg-1),and a dexamethasone group(0.2 mg·kg-1).After four weeks of intervention,the body weight and pulmonary function of rats were examined;the pathological changes of lung tissue were observed by hematoxylin-eosin(HE)staining;the mitochondrial structure of lung tissue was observed by transmission electron microscope(TEM);the levels of malondialdehyde(MDA),reduced glutathione(GSH),Fe2+,and total iron ions in lung tissue were detected by biochemical assays;the inflammatory factor levels in serum were measured by enzyme-linked immunosorbent assay(ELISA)kits;the protein expressions of Nrf2,SLC7A11,and GPX4 in lung tissue were detected by Western blot;the mRNA levels of Nrf2,SLC7A11,and GPX4 in lung tissue were determined by real-time quantitative polymerase chain reaction(RT-qPCR).The results show that compared with those in the model group,the rats in the Guben Kechuan Granule group exhibit significantly increased body weight,improved pulmonary function,and alleviated pathological injury and inflammation in lung tissue.The levels of tumour necrosis factor-α(TNF-α),interleukin-1β(IL-1β),interleukin-6(IL-6),interleukin-8(IL-8),and transforming growth factor-β(TGF-β)in serum were markedly decreased,while the level of interleukin-10(IL-10)was significantly elevated.Mitochondrial damage in lung tissue was significantly alleviated,with intact double-layer membrane structure and recovered morphology of inner membrane cristae.In addition,the levels of MDA,Fe2+,and total iron ions in lung tissue were reduced,whereas the GSH level was restored.These findings demonstrate that Guben Kechuan Granules could effectively alleviate oxidative stress and ferroptosis,improve pulmonary function,and alleviate inflammation in COPD rats.Molecular mechanistic studies reveal that the mice in the Guben Kechuan Granule group exhibit significantly up-regulated protein and mRNA expressions of Nrf2,SLC7A11,and GPX4 in lung tissue,compared with those in the model group.In summary,Guben Kechuan Granules can effectively improve pulmonary function and alleviate inflammation in COPD rats.Its action mechanism may be associated with activating the Nrf2/SLC7A11/GPX4 pathway and inhibiting ferroptosis in lung tissue.

于文海;王倩;何佳佳;张永生

北京中医药大学,北京 100029北京中医药大学,北京 100029北京中医药大学,北京 100029北京中医药大学 东方医院,北京 100078

慢性阻塞性肺疾病铁死亡炎症水平机制

chronic obstructive pulmonary diseaseferroptosisinflammatory levelmechanism

《中国中药杂志》 2026 (18)

5216-5224,9

国家中医药管理局第五批全国中医优秀人才研修项目(国中医药办人教函[2022]1号)吴阶平医学基金会科研专项(320.6750.2025-29-6)中央高水平中医医院临床科研业务费——"卓远"工程国家级人才精准培育项目(Dfrczy-2024gjrc004)

10.19540/j.cnki.cjcmm.20260428.901

评论